Byoung Seok Ye1, Eun Young Jang2, Seong Yoon Kim3, Eun-Joo Kim4, Sun Ah Park5, Yunhwan Lee6, Chang Hyung Hong7, Seong Hye Choi8, Bora Yoon9, Soo Jin Yoon10, Hae Ri Na11, Jae-Hong Lee12, Jee H Jeong13, Hee Jin Kim2, Duk L Na2, Sang Won Seo2,14,15. 1. Department of Neurology, Yonsei University College of Medicine, Seoul, Korea. 2. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 3. Department of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 4. Department of Neurology, Pusan National University School of Medicine, Pusan, Korea. 5. Department of Neurology, Soonchunhyang University College of Medicine, Bucheon, Korea. 6. Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Korea. 7. Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea. 8. Department of Neurology, Inha University School of Medicine, Incheon, Korea. 9. Department of Neurology, Konyang University Hospital, College of Medicine, Konyang University, Daejeon, Korea. 10. Department of Neurology, Eulji University College of Medicine, Daejeon, Korea. 11. Department of Neurology, Bobath Memorial Hospital, Seongnam, Korea. 12. Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 13. Department of Neurology, Ewha Womans University School of Medicine, Seoul, Korea. 14. Neuroscience Center, Samsung Medical Center. 15. Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University.
Abstract
BACKGROUND AND OBJECTIVE: We investigated the influence of body mass index (BMI) status at baseline and changes in BMI over a follow-up period on the development of dementia in amnestic mild cognitive impairment (aMCI) patients. METHODS: The longitudinal data of 747 aMCI patients were used to investigate the relationships among baseline BMI status, subsequent changes in BMI (median follow-up duration: 1.6 years, interquartile range: 1.0-2.3 years), and risk of progression to probable Alzheimer's disease dementia (pADD). The aMCI patients were classified into underweight, normal weight, overweight, and obese subgroups, and further categorized into increased BMI, stable BMI, and decreased BMI subgroups during follow-up using a 4% mean annual change in BMI cut-off value. RESULTS: Compared to the normal weight group, the underweight group had a higher risk of pADD (hazard ratio [HR]: 1.89, 95% confidence interval [CI]: 1.07-3.37) while the obese group had a lower risk (HR: 0.70, 95% CI: 0.49-0.999). After controllingfor baseline BMI status, the decreased BMI (HR: 2.29, 95% CI: 1.41-3.72) and increased BMI (HR: 3.96, 95% CI: 2.62-6.00) groups were at increased risk of progression to pADD. CONCLUSIONS: Our findings suggested that underweight at baseline was associated with a higher risk of progression to pADD, while obesity at baseline predicted a lower risk. Furthermore, significant changes in BMI during the follow-up period reflected an increased risk of progression to pADD, regardless of BMI status at baseline.
BACKGROUND AND OBJECTIVE: We investigated the influence of body mass index (BMI) status at baseline and changes in BMI over a follow-up period on the development of dementia in amnestic mild cognitive impairment (aMCI) patients. METHODS: The longitudinal data of 747 aMCI patients were used to investigate the relationships among baseline BMI status, subsequent changes in BMI (median follow-up duration: 1.6 years, interquartile range: 1.0-2.3 years), and risk of progression to probable Alzheimer's disease dementia (pADD). The aMCI patients were classified into underweight, normal weight, overweight, and obese subgroups, and further categorized into increased BMI, stable BMI, and decreased BMI subgroups during follow-up using a 4% mean annual change in BMI cut-off value. RESULTS: Compared to the normal weight group, the underweight group had a higher risk of pADD (hazard ratio [HR]: 1.89, 95% confidence interval [CI]: 1.07-3.37) while the obese group had a lower risk (HR: 0.70, 95% CI: 0.49-0.999). After controllingfor baseline BMI status, the decreased BMI (HR: 2.29, 95% CI: 1.41-3.72) and increased BMI (HR: 3.96, 95% CI: 2.62-6.00) groups were at increased risk of progression to pADD. CONCLUSIONS: Our findings suggested that underweight at baseline was associated with a higher risk of progression to pADD, while obesity at baseline predicted a lower risk. Furthermore, significant changes in BMI during the follow-up period reflected an increased risk of progression to pADD, regardless of BMI status at baseline.
Entities:
Keywords:
Alzheimer’s disease; amnestic mild cognitive impairment; body mass index; dementia; progression
Authors: Michael L Alosco; Jonathan Duskin; Lilah M Besser; Brett Martin; Christine E Chaisson; John Gunstad; Neil W Kowall; Ann C McKee; Robert A Stern; Yorghos Tripodis Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Lilah M Besser; Michael L Alosco; Liliana Ramirez Gomez; Xiao-Hua Zhou; Ann C McKee; Robert A Stern; John Gunstad; Julie A Schneider; Helena Chui; Walter A Kukull Journal: J Neuropathol Exp Neurol Date: 2016-08-11 Impact factor: 3.685
Authors: Insa Feinkohl; Gunnar Lachmann; Tobias Pischon; Claudia Spies; Wolf-Rüdiger Brockhaus; Friedrich Borchers; Sophie K Piper; Thomas H Ottens; Hendrik M Nathoe; Anne-Mette Sauer; Jan M Dieleman; Finn M Radtke; Diederik van Dijk Journal: Clin Epidemiol Date: 2018-07-25 Impact factor: 4.790